Background Gilles de la Tourette syndrome (TS) is a childhood onset neuropsychiatric disorder typified by both motor and phonic tics as well as comorbid psychiatric symptoms [5, 6]. Deep brain stimulation (DBS) is currently an experimental treatment strategy for patients with severe and medication refractory TS [22, 28, 29]. Collective evidence drawn from neuroimaging [4, 30, 32], stereotactic lesions [1, 10, 21],